Back to results
US 2007/0191379 A1Published application
ABCA1 elevating compounds
AssigneeCV Therapeutics, Inc.
InventorsMatthew Abelman, Robert Jiang, Jeff Zablocki, Dmitry Koltun, Melanie Boze
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds useful for increasing cellular ATP binding cassette transporter ABCA1 production in mammals, and to methods of using such compounds in the treatment of coronary artery diseases, dyslipidiemias and metabolic syndrome. The invention also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.
Claims15
A compound having the structure of Formula I:
- wherein:
- R1 and R2 are independently optionally substituted lower alkyl;
- R3 and R4 are hydrogen;
- R5 is hydrogen or optionally substituted lower alkoxy;
- R6 is hydrogen or optionally substituted lower alkyl;
- R7 and R8 are hydrogen;
- R20 is optionally substituted heteroaryl or —SR14 in which R14 is hydrogen, optionally substituted lower alkyl, optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted heterocyclyl;
- A and D are independently 5 or 6 membered monocyclic heterocyclic, monocyclic heteroaryl, or monocyclic aryl rings;
- and
- X is oxygen, sulfur, —S(O)—, —S(O)2— or —NR16—, in which R16 is hydrogen, optionally substituted lower alkyl, optionally substituted aryl, —C(O)R12, or —S(O)2R13.
7 more elements
Dependencies are inferred from the claim text.